Page Inspect

Clinical Diagnostics Technology & Disease Research News | 360Dx    Skip to main content

## Sister Publication Links

- GenomeWeb
- 360Dx
- Precision Medicine Online
- PMLS Events

- RSS Feeds
- Visit 360Dx on Twitter
- Visit 360Dx on LinkedIn

Premium Trial:

Request an Annual Quote

## User account menu

- My 360Dx
- Profile
- Newsletters
- My Topics
- Reading List
- Log out

Log in

Subscribe

Menu

Close Menu

## Main navigation

- My 360Dx
- Profile
- Newsletters
- My Topics
- Reading List
- Log out
- Business & Policy
- Business News
- Research Funding
- Policy & Legislation
- Regulatory News
- Reimbursement
- Clinical Lab Management
- Diagnostics
- Molecular Diagnostics
- Immunoassays
- Tissue-Based Testing
- Clinical Chemistry
- Hematology/Coagulation
- Point-of-Care Testing
- Companion Diagnostics
- Disease Areas
- Cancer
- Infectious Disease
- Cardiovascular Disease
- Neurological & Psychological Disease
- Autoimmune Disease
- Inherited Disease
- Reproductive Health
- Respiratory
- Gastrointestinal
- COVID-19
- Resources
- Webinars
- White Papers
- Job Listings
- New Products
- People in the News
- FDA 510(k) Tracker: IVD Tests and Instruments
- Coronavirus Test Tracker
- Partner Content

Premium Trial:

Request an Annual Quote

Log in

Subscribe

## Quest Diagnostics Seeing Strong Growth in Blood-Based Alzheimer's Testing

Premium

During a talk at the Jefferies Healthcare Services Conference this week, CFO Sam Samad said the business has exceeded the company's expectations.

## With Rebrand and US Launch of Depression Test, NeuroKaire Enters Precision Psychiatry Testing Market

Premium

The BrightKaire test converts stem cells to neurons and exposes those neurons to different antidepressants to determine how patients might react to treatments.

## Brewing Legislation Aims to Improve Competitiveness of European IVD Makers

Premium

Industry representatives have voiced their support for the Biotech Act, hoping it will improve financing and institutional support of IVD makers.

## Cancer Screening Event Puts Spotlight on Improving Test, Counseling, Downstream Services Access

Premium

Some genetics experts felt the event raised awareness of the importance of testing, while others had mixed feelings amid growing healthcare access worries.

## Meridian Bioscience Sees Future Success in Dual Role as Reagent Supplier, Dx Developer

Premium

As a relatively new subsidiary of SD Biosensor, Meridian is growing its product portfolio within its life sciences and diagnostics businesses.

## Inflammatix Sepsis Test Outperformed Established Biomarkers, Study Finds

Premium

In total, three studies were published in Nature Medicine that together describe methods to provide more precise diagnoses of sepsis and acute illnesses.

## Artera Presents Clinical Validation, Test Comparison Data for AI-Driven Digital Pathology Tech

Premium

At ASTRO, Artera presented clinical validation data on its prostate cancer test in an Asian population,and showed how the test may complement gene expression-based approaches.

Business, Policy & Funding

- ## Top Five Articles on 360Dx Last Week: FDA Clearance, CE Mark for Hologic Gastrointestinal Panels; More
- ## Startup Kihealth Raises $5M in Oversubscribed Seed Round
- ## Gene Solutions, AMPATH Partner to Open NGS Lab in India
- ## In Brief This Week: Foundation Medicine, Biodesix, Certest Biotec, WHO
- ## Cancer Screening Event Puts Spotlight on Improving Test, Counseling, Downstream Services Access

Premium

Diagnostics

- ## Italian Partners to Develop Lung Cancer, HER3-Targeted Therapies, Diagnostics
- ## Gene Solutions, AMPATH Partner to Open NGS Lab in India
- ## Medicare Contractor WPS Proposes Coverage of Non-NGS-Based Predictive Cancer Tests
- ## Meridian Bioscience Sees Future Success in Dual Role as Reagent Supplier, Dx Developer

Premium
- ## Revvity, Sanofi Partner on Type 1 Diabetes Screening Assay

Disease Areas

- ## Top Five Articles on 360Dx Last Week: FDA Clearance, CE Mark for Hologic Gastrointestinal Panels; More
- ## Startup Kihealth Raises $5M in Oversubscribed Seed Round
- ## Italian Partners to Develop Lung Cancer, HER3-Targeted Therapies, Diagnostics
- ## Cancer Screening Event Puts Spotlight on Improving Test, Counseling, Downstream Services Access

Premium
- ## Revvity, Sanofi Partner on Type 1 Diabetes Screening Assay

Clinical Lab Management

- ## Quest Diagnostics Seeing Strong Growth in Blood-Based Alzheimer's Testing

Premium
- ## Labcorp, Natera Reach Settlement in Genetic Testing Patent Dispute
- ## Quest Diagnostics Inks Deal for Epic Systems' Lab Software, Services
- ## FDA Rescinds Final Rule on Laboratory-Developed Tests
- ## HHS OIG Calls for Mandatory Lab Emergency Plans, Industry Pushes for Federal Support

Premium

Breaking News

- ## Top Five Articles on 360Dx Last Week: FDA Clearance, CE Mark for Hologic Gastrointestinal Panels; More
- ## Startup Kihealth Raises $5M in Oversubscribed Seed Round
- ## Italian Partners to Develop Lung Cancer, HER3-Targeted Therapies, Diagnostics
- ## Gene Solutions, AMPATH Partner to Open NGS Lab in India
- ## In Brief This Week: Foundation Medicine, Biodesix, Certest Biotec, WHO
- ## Medicare Contractor WPS Proposes Coverage of Non-NGS-Based Predictive Cancer Tests

What's Popular?

- ## Meridian Bioscience Sees Future Success in Dual Role as Reagent Supplier, Dx Developer

Premium
- ## Inflammatix Sepsis Test Outperformed Established Biomarkers, Study Finds

Premium
- ## Quest Diagnostics Seeing Strong Growth in Blood-Based Alzheimer's Testing

Premium
- ## Revvity, Sanofi Partner on Type 1 Diabetes Screening Assay
- ## Hologic Gains FDA 510(k) Clearance, CE Marking for Gastrointestinal Bacterial Pathogen Panels

##### Sponsorships

## Footer

- About us
- Advertise
- Contact
- FAQ
- Jobs
- Sitemap
- Submit A Tip

Privacy Policy.  Terms & Conditions. Copyright © 2025 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.